Troels Koch MSc PhD
VP & CTO

Troels Koch is a co-founder of Cureon A/S, which merged with Pantheco A/S to form Santaris Pharma. He was previously Director of Chemistry & Operations at PNA Diagnostics A/S (a former subsidiary of Boehringer Mannheim and Hoffmann-La Roche).

Troels Koch is also a co-founder of Exiqon A/S.

Troels Koch has worked intensively with DNA, LNA, and PNA oligonucleotide technologies in the diagnostics and pharmaceutical industries. He has substantial experience in managing R&D activities, intellectual property rights and quality systems in biotech companies. He is the author and co-author of 42 scientific publications and books and 22 patents, and he is often invited to speak at scientific conferences and symposiums.

Troels Koch holds a MSc and a PhD in bioorganic chemistry obtained from the University of Copenhagen/University of Illinois. He is post doc at the University of Copenhagen.